BARD1 and cancer: It has been shown that this BRCA1–BARD1 complex possesses E3-ubiquitin (Ub) ligase activity, and this activity can be disrupted by cancer-derived mutations, underscoring the critical role of this enzymatic function in suppressing tumorigenesis (Baer and Ludwig, 2002).